Breaking News

Sterling Pharma Solutions Invests $3M in Germantown, WI Facility

Expands its integrated antibody-drug conjugate (ADC) development and manufacturing capabilities.

Author Image

By: Charlie Sternberg

Associate Editor

Sterling Pharma Solutions, a global contract development and manufacturing organization, has announced a $3 million investment at its Germantown, WI facility, to expand its integrated antibody-drug conjugate (ADC) development and manufacturing capabilities.   Sterling has commissioned a dedicated GMP suite at the site, which will incorporate the installation of a modular isolator with containment capabilities down to less than 1 nanogram per cubic meter.   The isolator has the capacity to un...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters